431 Results (Page 1 of 18)
Brazil Markets Research Reports
Brazil Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the Brazil Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Brazil Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
Brazil Retail Pharmacy Market Analysis
Brazil's Retail Pharmacy Market is projected to grow from $25.97 Bn in 2022 to $47.70 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-30. The market is highly competitive, with a large number of players operating in the market, including local and international retail pharmacy chains, independent pharmacies, and online pharmacies. Drogaria Sao Paulo is one of the largest retail pharmacy chains in Brazil, with more than 1,300 stores across the country.
Brazil Central Nervous System (CNS) Therapeutics Market Analysis
The Brazil Central Nervous System (CNS)Therapeutics Market was valued at US $5.250 Bn in 2022 and is predicted to grow at a CAGR of 7.4% from 2023 to 2030, to US $9.294 Bn by 2030. The key drivers of this industry include the increasing prevalence of CNS diseases, government initiatives, and new treatment options. The industry is primarily dominated by players such as Pfizer, Novartis, Biogen, AstraZeneca, Eli Lilly, Eurofarma, Merck, and Abbott among others.
Brazil Electronic Records Management Solutions Market Analysis
Brazil's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. Brazil’s Electronic Records Management Solutions market will grow the adoption of electronic records management systems (ERMS) is rising in the Brazilian healthcare industry, which is constrained by a number of market factors. The key market players are F2X Group, Grupo Mult, NEOCLOUD, QI Consultoria e Sistemas, SoftExpert, and others.
Brazil Myeloproliferative Disorders (MPD) Therapeutics Market Analysis
Brazil Myeloproliferative Disorders (MPD) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The market for drugs to treat myeloproliferative disorders is expected to expand as a result of the rising prevalence of the different myeloproliferative disorders, the existence of promising pipeline products, regular product approvals, and rising R&D expenditures on the creation of new drugs for the MPD Treatment market. Major global players in this market are Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Novartis AG, Teva Pharmaceutical Industries Ltd, Bristol Myers Squibb Company, GSK Plc, Bayer AG, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International Gmbh, Sanofi.
Brazil Adrenoleukodystrophy (ALD) Drugs Market Analysis
Brazil Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Global Adrenoleukodystrophy (ALD) drugs Market.
Brazil Pain Management Devices Market Analysis
This report presents a strategic analysis of the Brazil Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Brazil Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Brazil Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
Brazil Mucopolysaccharidosis I (MPS-I) Drugs Market Analysis
Brazil Mucopolysaccharidosis I (MPS-I) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in Mucopolysaccharidosis I (MPS-I) Drugs Market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Drugs, Abeona Drugs, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Drugs, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Brazil's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $93 Mn in 2022 to $216 Mn in 2030 with a CAGR of 11.20% for the year 2022-30. The expansion of the PNH therapeutics market in Brazil is anticipated to be fueled by the creation of new technologies and treatment options for PNH. For instance, the recent approval of eculizumab (a monoclonal antibody that targets the complement system for the treatment of PNH) has dramatically improved patient outcomes and is probably going to lead to a rise in the demand for PNH medicines in Brazil. The market is segmented by therapy, diagnostic test, and distribution channel. Some key players in this market include Aché Laboratórios, Eurofarma, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Brazil Oculopharyngeal Muscular Dystrophy (OPMD) Market Analysis
Brazil Oculopharyngeal Muscular Dystrophy (OPMD) market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Oculopharyngeal Muscular Dystrophy (OPMD)is growing due to increase spending in research and development activities by pharmaceutical companies, incentives provided by regulatory authorities like orphan drug designations and accelerated approval pathways, patient support and advocacy programmes which help to increase awareness about disease and provide support to patients. Bristol-Myers Squibb, BioMarin, Sarepta Therapeutics, Benitec Biopharma Inc., Bioblast Pharma, PTC Therapeutics, NS Pharma, Nobelpharma Co., Ltd ,Santhera Pharmaceuticals, Pfizer Inc. ,Marathon Pharmaceuticals, Fibrogen, GSK are the key global market players.
Brazil Mucopolysaccharidosis I (MPS-I) Therapeutics Market Analysis
Brazil Mucopolysaccharidosis I (MPS-I) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in this market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Brazil Chronic Myelogenous Leukemia Therapeutics Market Analysis
Brazil Chronic Myelogenous Leukemia Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Chronic granulocytic leukemia, often known as chronic myelogenous leukemia (CML), is a slowly progressive blood and bone marrow condition that most frequently affects adults in or after middle age and very infrequently affects children. Because of the rising incidence of the condition, the introduction of novel medications, and the expanding use of personalized medicine, the market for CML treatments is anticipated to expand gradually in the years to come. Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, and Sanofi are a few of the businesses that are now dominating the industry.
Brazil Artificial Intelligence (AI) in Diagnostics Market Analysis
Brazil's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.03 Bn in 2022 to $0.29 Bn by 2030, registering a CAGR of 36% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of chronic illnesses and the growing requirement for more accurate and efficient diagnostic instruments. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & HiLab.
Brazil Autoimmune Hemolytic Anemia Drugs Market Analysis
Brazil Autoimmune Hemolytic Anemia Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. A rise in the prevalence of certain autoimmune illnesses and malignancies, as well as increased funding for research into innovative interventions and growing demand for novel therapies, are all contributing to an increase in the market for medications to treat autoimmune hemolytic anaemia. Major global players in Autoimmune Hemolytic Anemia Drugs Market are F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Vertice Pharma, Concord Biotech, Alkem Labs, Dr. Reddy's Laboratories Ltd, Jubilant Life Sciences Ltd, Strides Pharma Science Limited, Mylan N.V., Novartis AG, Sanofi, Rigel Pharmaceuticals Inc, Incyte Corporation, Alexion Pharmaceuticals, Apellis Pharmaceuticals.
Brazil Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the Brazil Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Brazil Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
Brazil Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of Brazil's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Brazil's Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Brazil Alzheimer’s Therapeutics Market Analysis
Brazil Alzheimer’s Therapeutics Market was valued at $120 Mn in 2022 and is estimated to reach $259 Mn in 2030, exhibiting a CAGR of 10.1% during the forecast period. One of the main factors propelling the market's growth is the rising demand for Alzheimer's treatment pharmaceuticals as a result of the increasing prevalence of Alzheimer's disease among the aging population. Leading pharmaceutical companies that are currently working in the market are Pfizer, Biogen, Janssen, Eisai, Novartis, Roche, Lundbeck, Otsuka Pharmaceutical, Teva Pharmaceutical and Sun Pharmaceutical.
Brazil Infectious Disease Drugs Market Analysis
Brazil Infectious Disease Drugs Market valued at $2.96 Bn in 2023, projected to reach $4.25 Bn by 2030 with a 5.27% CAGR. The market is expanding due to increased healthcare spending, technological advancements, and awareness and education initiatives. The market is dominated by key players like Hypera Pharma, EMS S.A., AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Brazil Atopic Dermatitis Therapeutics Market Analysis
The Brazil Atopic Dermatitis Therapeutics Market was valued at US $308 Mn in 2022, and is predicted to grow at (CAGR) of 9.8% from 2023 to 2030, to US $650 Mn by 2030. The key drivers of this industry include the upward trend in prevalence of Atopic Dermatitis (AD), supportive government policies and shifting treatment preferences. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Bayer, GlaxoSmithKline, Merck among others.
Brazil Atherosclerosis Therapeutics Market Analysis
Brazil Atherosclerosis Therapeutics Market was valued at $70 Mn in 2022 and is estimated to reach $118 Mn in 2030, exhibiting a CAGR of 6.7% during the forecast period. The market for atherosclerosis therapeutics is expected to grow as a result of the growing incidence of cardiovascular diseases, which are being exacerbated by sedentary lifestyles, poor eating habits, and an aging population worldwide. The leading pharmaceutical companies presently operating in the market are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott, Johnson & Johnson, Teva Pharmaceutical, Roche, and Merck & Co.
Brazil HIV Drugs Market Analysis
Brazil HIV Drugs Market is at around $0.79 Bn in 2023 and is projected to reach $1.09 Bn in 2030, exhibiting a CAGR of 4.6% during the forecast period. The market is expanding due to factors such as the high prevalence of HIV/ AIDS, government initiatives and healthcare policies, and rising spending on healthcare. The market is dominated by key players like Oswaldo Cruz Foundation (Fiocruz), Biolab Sanus, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., and F. Hoffman-La Roche Ltd.
Brazil Antifungal Drugs Market Analysis
Brazil Antifungal Drugs Market is at around $0.4 Bn in 2023 and is projected to reach $0.55 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding as a result of rising fungal infections, improvements in healthcare infrastructure, and the development of antifungal drugs. The market is dominated by key players like EMS Farmaceutia S.A., Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Brazil Topical Pain Relief Market Analysis
Brazil Topical Pain Relief Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Topical Pain Relief market is growing globally due to the increase in incidence and prevalence of Chronic pain conditions such as arthritis, back pain, and musculoskeletal disorders, growing preference for non-opioid pain management due to addictive nature of opioid medications, ease of use and convenience of topical pain relief products, expanding product range and innovation, Increasing Consumer Awareness, Over-the-Counter Availability and rising healthcare expenditure. Advacare Pharma, GlaxoSmithKline Plc (GSK), Johnson & Johnson, Nestlé S.A., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi, Sun Pharmaceutical Industries Ltd are the key global market players in topical pain relief market.
Brazil Transdermal Skin Patches Market Analysis
Brazil Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.